Skip to main content

Want a detailed portfolio tracker?

GRI Bio (GRI) P/E (2024 - 2026)

GRI Bio (GRI) P/E from Sep 30, 2024 to Jul 21, 2026. The TTM GRI Bio (GRI) P/E is -0.03. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of GRI Bio (GRI)

YearP/EChange
2026-0.03-71.25%
2025-0.12-99.54%
2024-25.50N/A

Comparison GRI Bio (GRI) P/E with competitors

GRI Bio (GRI) P/E is -0.03.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-105.06%
NBYStablecoin Development Corp0.00-112.80%
ENLVEnlivex Ltd0.07-322.73%
FGENFibroGen Inc0.24-814.73%
CHRSCoherus Biosciences Inc0.85-2626.51%
FBIOFortress Biotech Inc0.95-2925.76%
ORMPOramed Pharmaceuticals Inc1.50-4575.36%
AGENAgenus Inc3.01-9061.14%
INVAInnoviva Inc3.15-9491.11%
VXRTVaxart Inc3.55-10669.35%
CRMDCorMedix Inc3.63-10903.69%
CVACCureVac N.V.4.45-13337.00%
GLPGGalapagos NV4.86-14567.35%
SRPTSarepta Therapeutics Inc4.88-14636.43%
ABEOAbeona Therapeutics Inc5.39-16141.32%
ABUSArbutus Biopharma Corp5.60-16760.96%
ZVRAZevra Therapeutics Inc5.89-17629.23%
SPROSpero Therapeutics Inc6.23-18645.19%
CGENCompugen Ltd6.31-18899.78%
RIGLRigel Pharmaceuticals6.87-20561.59%
SLXNSilexion Therapeutics Corp7.30-21824.10%
OMEROmeros Corporation9.26-27667.97%
AUPHAurinia Pharmaceuticals Inc9.58-28639.27%
PLXProtalix BioTherapeutics Inc10.89-32528.03%
ACADAcadia Pharmaceuticals Inc11.73-35021.79%
TBPHTheravance Biopharma Inc12.26-36610.64%
ADMAAdma Biologics Inc12.42-37075.15%
HRMYHarmony Biosciences Holdings Inc13.82-41249.77%
SABSSAB Biotherapeutics Inc14.14-42190.70%
NAGENiagen Bioscience Inc14.82-44221.14%
INCYIncyte Corp15.82-47211.85%
REGNRegeneron Pharmaceuticals Inc15.86-47313.39%
PBYIPuma Biotechnology Inc17.32-51657.73%
CPRXCatalyst Pharmaceuticals Inc17.44-52025.77%
EXELExelixis Inc17.54-52319.66%
TGTXTG Therapeutics Inc18.97-56571.69%
MDXGMimedx Group Inc20.55-61295.39%
XOMAXOMA Royalty Corp22.87-68211.50%
ARGXArgen X SE24.30-72449.54%
CTMXCytomX Therapeutics Inc24.82-74007.13%
XOMAOXOMA Royalty Corp25.34-75566.51%
HALOHalozyme Therapeutics Inc25.62-76396.97%
XOMAPXOMA Royalty Corp25.67-76535.13%
VRTXVertex Pharmaceuticals Inc27.99-83456.90%
RPRXRoyalty Pharma plc - Class A28.69-85519.79%
SLNOSoleno Therapeutics Inc29.02-86495.85%
ASNDAscendis Pharma A/S30.09-89682.50%
LGNDLigand Pharmaceuticals Inc - Class B37.91-112986.52%
APLSApellis Pharmaceuticals Inc39.02-116289.29%
BMRNBiomarin Pharmaceutical Inc42.21-125789.67%
KRYSKrystal Biotech Inc45.34-135114.38%
ONCBeiGene Ltd69.54-207163.18%
PHARPharming Group N.V.75.03-223495.70%
TECHBio-Techne Corp101.96-303690.67%
VCELVericel Corp109.92-327401.13%
ALNYAlnylam Pharmaceuticals Inc117.96-351352.19%
GMABGenmab140.29-417828.98%
TLXTelix Pharmaceuticals Ltd162.15-482925.34%
CORTCorcept Therapeutics Inc212.86-633903.32%